Cargando…
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
SUMMARY: Previous studies evaluated the association between proton pump inhibitor (PPI) use and subsequent fracture risk, but they showed ambiguous results. Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causal r...
Autores principales: | Pouwels, S., Lalmohamed, A., Souverein, P., Cooper, C., Veldt, B. J., Leufkens, H. G., de Boer, A., van Staa, T., de Vries, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034906/ https://www.ncbi.nlm.nih.gov/pubmed/20585937 http://dx.doi.org/10.1007/s00198-010-1337-8 |
Ejemplares similares
-
Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands
por: de Vries, F., et al.
Publicado: (2007) -
Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study
por: Pouwels, S., et al.
Publicado: (2009) -
Use of anti-depressants and the risk of fracture of the hip or femur
por: van den Brand, M. W. M., et al.
Publicado: (2009) -
Use of anti-depressants and the risk of fracture of the hip or femur
por: van den Brand, M. W. M., et al.
Publicado: (2009) -
Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers
por: de Vries, F., et al.
Publicado: (2010)